News Ex-Allergan CEO Saunders pops up again in ‘blank cheque’ com... Brent Saunders has been out of the limelight for a few months since departing Allerg
News Norgine gets first EU approval for WHIM syndrome therapy Patients in the EU with the ultra-rare disease WHIM syndrome now have their first approved treatment, Norgine's Xolremdi.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
